Richardson R M, Haribabu B, Ali H, Snyderman R
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.
J Biol Chem. 1996 Nov 8;271(45):28717-24. doi: 10.1074/jbc.271.45.28717.
Cross-desensitization among receptors for peptide chemoattractants have been shown to involve two independent processes, receptor phosphorylation and inhibition of phospholipase C (PLC) activation. Receptors for lipid chemoattractants, i.e. platelet activating factor (PAF) and leukotriene B4, did not inhibit the responses of peptide chemoattractant receptors, suggesting distinct signaling pathways. To examine cross-desensitization between receptors for lipid and peptide chemoattractants, cDNA encoding the PAF receptor (PAFR) was co-expressed into RBL-2H3 cells with cDNAs encoding receptors for either formylated peptides (FR), a product of the fifth component of complement (C5aR) or interleukin-8 A (IL-8RA). PAFR was homologously phosphorylated and desensitized by PAF, and cross-phosphorylated and cross-desensitized by fMet-Leu-Phe, C5a, and IL-8. In contrast, the receptors for peptide chemoattractants were neither cross-phosphorylated nor cross-desensitized by PAF. Staurosporine blocked cross-phosphorylation and cross-desensitization of the PAFR by peptide chemoattractants. Truncation of the cytoplasmic tail of PAFR (mPAFR) abolished its homologous and cross-phosphorylation. mPAFR was also resistant to cross-desensitization by peptide chemoattractants at the level of PLC activation. Interestingly, mPAFR mediated a sustained Ca2+ mobilization in response to PAF and was more active in inducing GTPase activity, phosphoinositide hydrolysis, secretion, and phospholipase D activation than the wild type PAFR. In contrast to PAFR, stimulation of the mPAFR cross-phosphorylated and cross-desensitized responses to IL-8RA. As expected, FR, which is resistant to cross-phosphorylation by C5aR and IL-8RA, was not phosphorylated by mPAFR. However, unlike C5aR and IL-8RA, mPAFR did not inhibit the ability of FR to activate PLC. Blocking Ca2+ influx inhibited mPAFR-mediated sustained Ca2+ response, phospholipase D activation and secretion, but not phosphoinositide hydrolysis and cross-phosphorylation and cross-desensitization of IL-8RA. The data herein suggest that cross-desensitization of PAFR by peptide chemoattractants is solely due to receptor phosphorylation. The PAFR and the peptide chemoattractant receptors do not cross-regulate each other at the level of PLC, suggesting distinct regulatory pathways.
已表明肽类趋化因子受体之间的交叉脱敏涉及两个独立过程,即受体磷酸化和磷脂酶C(PLC)激活的抑制。脂质趋化因子的受体,即血小板活化因子(PAF)和白三烯B4,并不抑制肽类趋化因子受体的反应,这表明信号传导途径不同。为了研究脂质和肽类趋化因子受体之间的交叉脱敏,将编码PAF受体(PAFR)的cDNA与编码甲酰化肽(FR)、补体第五成分产物(C5aR)或白细胞介素-8A(IL-8RA)受体的cDNA共表达于RBL-2H3细胞中。PAFR被PAF同源磷酸化并脱敏,被甲酰甲硫氨酸-亮氨酸-苯丙氨酸、C5a和IL-8交叉磷酸化并交叉脱敏。相反,肽类趋化因子受体既不被PAF交叉磷酸化也不被其交叉脱敏。星形孢菌素阻断了肽类趋化因子对PAFR的交叉磷酸化和交叉脱敏。PAFR细胞质尾的截短(mPAFR)消除了其同源和交叉磷酸化。mPAFR在PLC激活水平上也对肽类趋化因子的交叉脱敏具有抗性。有趣的是,mPAFR介导了对PAF的持续Ca2+动员,并且在诱导GTP酶活性、磷酸肌醇水解、分泌和磷脂酶D激活方面比野生型PAFR更活跃。与PAFR相反,mPAFR的刺激对IL-8RA进行了交叉磷酸化和交叉脱敏反应。正如预期的那样,对C5aR和IL-8RA的交叉磷酸化具有抗性的FR不被mPAFR磷酸化。然而,与C5aR和IL-8RA不同,mPAFR并不抑制FR激活PLC的能力。阻断Ca2+内流抑制了mPAFR介导的持续Ca2+反应、磷脂酶D激活和分泌,但不抑制磷酸肌醇水解以及IL-8RA的交叉磷酸化和交叉脱敏。本文的数据表明,肽类趋化因子对PAFR的交叉脱敏完全是由于受体磷酸化。PAFR和肽类趋化因子受体在PLC水平上不相互交叉调节,这表明存在不同的调节途径。